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Idiopathic acute eosinophilic pneumonia (IAEP), characterized by acute febrile respiratory failure 
associated with diffuse radiographic infiltrates and pulmonary eosinophilia, is rarely reported in 
children. Diagnosis is based on an association of characteristic features including acute respiratory 
failure with fever, bilateral infiltrates on the chest X-ray, severe hypoxemia and bronchoalveolar lavage 
fluid >25% eosinophils or a predominant eosinophilic infiltrate in lung biopsies in the absence of any 
identifiable etiology. We present a 14-month-old girl who was admitted to our pediatric intensive care 
unit because of acute respiratory distress. She had a fever, dry cough, and progressive dyspnea for 
1 day. Chest X-ray showed multifocal consolidations, increased interstitial markings, parenchymal 
emphysema and pneumothorax. IAEP was confirmed by marked pulmonary infiltrates of eosinophils 
in the lung biopsy specimen. Most known causes of acute eosinophilic pneumonia, such as exposure 
to causative drugs, toxins, second-hand smoking and infections were excluded. Her symptoms were 
resolved quickly after corticosteroid therapy. 
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Introduction
Acute eosinophilic pneumonia is a rare disease that causes an acute onset of res­
piratory distress and marked pulmonary infiltrates of eosinophils
1,2). It presents as 
acute pneumonia in previously healthy subjects, with possible respiratory failure. 
Various factors including infections, drugs, toxins, systemic eosinophilic disorders 
and smoking can cause this disease
3,4). Cases in which such causes are not apparent 
are designated idiopathic acute eosin  ophilic pneumonia (IAEP). The main pathologic 
finding is the presence of organizing diffuse alveolar damage together with marked 
alveolar and bronchiolar infiltrates of eosinophils
1). Approximately two­thirds of 
patients with IAEP need mechanical ventilation because of acute respiratory distress. 
However, once the diagnosis is made, complete clinical and ra  diological recovery 
without relapse occurs rapidly with corticosteroid therapy
3). We pre  sent the case of 
a very young girl who had no apparent history of exposure to the possible causative 
factors and suffered from acute respiratory distress. After IAEP was confirmed by lung 
biopsy, she recovered completely in response to corti  costeroids without relapse.  http://dx.doi.org/10.3345/kjp.2013.56.1.37
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Case report
A previously healthy 14­month­old girl was transferred 
to our hospital because of fever, dry cough and progressive 
dyspnea for 1 day. On physical examination, she exhibited 
marked respiratory distress and marked chest wall retractions. 
Her temperature was 38.6℃, blood pressure was 110/60 mmHg, 
pulse rate was 180/min, and respiratory rate was 75/min. Her 
breathing sounds were decreased, and crackles and wheezing 
were audible in both lungs but without cardiac murmurs. 
Complete blood cell counts revealed the following: white 
blood cells, 6,900/uL (neutrophils, 76%; lymphocytes, 19.3%; 
monocytes, 4.3%; and eosinophils, 0.1%); hemoglobin, 10.7 g/
dL; and platelets, 277,000/µL. After 5 L/min of oxygen was 
applied through a nasal prong, arterial blood gas analysis 
showed the following: pH, 7.39; PaCO2, 43.5 mmHg; PaO2, 73.7 
mmHg; HCO3, 23.9 mEq/L; base excess, ­1.6 mEq/L; and oxy­
gen saturation, 94.1%. Other blood biochemical tests were 
normal. Chest radiography showed patchy consolidations in 
the right lower lung, bilateral peribronchial infiltrations and 
pneumothorax in the left upper lung (Fig. 1A). High­resolution 
computed tomography (CT) of the chest showed multifocal 
ground­glass opacity, increased interstitial lung markings, 
paren  chymal emphysema and pneumothorax (Fig. 1B, C). 
Further workup results were negative for rheumatoid factors, 
antinuclear antibody, antineutrophil cytoplasmic antibody and 
fluorescent antinuclear antibody. Serum humoral antibody 
levels were normal (immunoglobulin [Ig] G, 738.0 mg/dL; IgM, 
357.0 mg/dL; IgA, 42.0 mg/dL; and IgE, 11.3 IU/mL). T cell sub­
sets were also within normal limits (lymphocytes, 4,643 /µL; 
CD4+T cells, 1,518/µL; CD8+T cells, 931/µL; and CD4+/CD8+ T 
cells, 1.63) and the serum levels of C3, C4, and CH50 were 124 
mg/dL, 19.1 mg/dL, and 38.0 U/mL, respectively. 
Differential diagnoses, including severe community­ac­
quired pneumonia, acute interstitial pneumonia (AIP), aspiration 
pneu  monia and acute hypersensitivity pneumonitis, were ex­
cluded. Blood and sputum cultures for bacteria and fungi were 
negative. Antibodies for Mycoplasma pneumoniae, Chlamydia 
tra  chomatis, Rickettsia tsutsugamushi and Ebstein­Barr virus 
were negative. Parasitic infestations were excluded by the ne  ga­
tive results of tests for specific antibodies for Cysticercus, Spar­
ganum, Paragonimus, and Clonorchis. No respiratory viruses 
except human bocavirus (HBoV) were detected in the polymerase 
chain reaction (PCR) of her nasopharyngeal aspirates. Despite 
broad spectrum antibiotics and supportive care, the patient 
continued to worsen over the next 48 hours, requiring a positive 
end­expiratory pressure of 10 cmH2O and a 75% fraction of 
inspired oxygen to maintain an oxygen saturation of 90%. 
A lung biopsy was performed on the 5th hospital day and 
de  monstrated marked infiltration of eosinophils to alveolar 
spaces, peribronchiolar tissues and interstitium (Fig. 2A, B). 
There was no evidence of viral (cytomegalovirus, Epstein­
Barr virus, and human immunodeficiency virus), bacterial 
(Chlamydia tracho  matis, Mycoplasma pneumoniae, and My­
cobacterium tuberculosis), or fungal infection (Pneumo  cystis 
jiroveci) from the lung biopsy specimens.
Intravenous corticosteroid pulse therapy (methylprednisolone 
30 mg/kg) was begun. The patient’s pulmonary status rapidly 
improved, requiring less ventilator support and showing clear­
ing of infiltrates on chest X­rays (Fig. 3A, B). Three days after 
the initiation of steroid therapy, the patient was successfully 
extubated. She was eventually discharged on the 18th day in 
good condition with a course of oral prednisone therapy tapered 
for a further 14 days. 
Discussion
IAEP rarely occurs in children
5). It is mostly manifested 
by acute onset of fever, dry cough, dyspnea, tachypnea and/
Fig. 1. (A) Chest radiograph on admission shows diffuse bilateral pulmonary infiltrates and pleural effusion. (B, C) High-resolution 
computed tomography scan showing multifocal consolidations, ground-glass attenua  tion, increased interstitial lung markings, 
parenchymal emphysema, pneu  mothorax and thickened bronchova  scular bundles. 
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or pleural pain. Diagnostic criteria for IAEP are as follows: 1) 
acute onset of febrile illness (usually less than 7 days), 2) diffuse 
bilateral pulmonary infiltrates, 3) hypoxemic respiratory fail  ­
ure, 4) lung eosinophilia (bronchoalveolar lavage [BAL] fluid 
eosinophilia >25% or predominance of eosinophils in lung 
biopsy), and 5) no known causes of acute eosinophilic lung 
disease
6). The favorable res  ponse of IAEP to corticosteroid 
therapy is characteristic and recurrence is not described
3). Our 
patient met the clinical defini  tion, including the acute onset of 
fever, respiratory failure and alveolar infiltration of eosinophils 
without definitive causes. To the best of our knowledge, this is 
the first case of IAEP in a very young girl. 
The causes of eosinophilic pneumonia are various, including 
smoking, infections, drugs or inhaled agents, and history of dust 
exposure
4,6,7). In our patient, such causes were absent, and we 
considered it to be idiopathic. HBoV was detected by the PCR 
of our patient’s nasopharyngeal aspirates. Viruses are a rare 
cause of acute eosinophilic pneumonia. There has been only 
one report of acute eosinophilic pneumonia which was caused 
by the 2009 influenza A (H1N1)
8). HBoV has not yet been re­
ported as a causative agent of eosinophilic pneumonia. Our 
patient had cold symptoms 7 days before the onset of clinical 
symptoms. HBoV infections are ubiquitous and the virus can 
be detected in the upper airway for up to 2 months following 
acute infection
9). Furthermore, the seroprevalence of HBoV 
was determined to be up to 58% in children aged <2 years
10). 
It is conceivable that HBoV primarily acts as a silent virus 
in infants, occasionally causing illnesses rather than being 
a serious pathogen
11). Fur  the  rmore, although HBoV related 
life­threatening respiratory infections were reported
12,13), we 
couldn’t confirm their causal relationship in our presented 
case because viral load was mea  sured neither from respiratory 
aspirates nor from blood. In addition, reported cases showed 
neither a lung eosinophilia nor a favorable response to steroid 
treatment which are distinct charac  teristics for acute eosinophilic 
pneumonia. Thus, we thought that the HBoV detected in our 
Fig. 2. (A) Histopathologic findings of the lung. Marked infiltration of eosinophils is seen in the peri-
bron  chiolar and alveolar spaces (H&E, ×100). (B) The alveolar walls are edematous and contain 
eosinophilic and lymphocytic infiltrates, but there are no granulomas or vasculitis (H&E, ×400).
A                                                 B 
Fig. 3. Chest radiograph (A) and high-resolution computed tomography scan (B) showing a 
significant improvement after corticosteroid therapy. 
A                                        Bhttp://dx.doi.org/10.3345/kjp.2013.56.1.37
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patient was a pathogen of the previous upper respiratory infec­
tion rather than a cau  sa  tive agent of the current illness. To 
date, the causes or mecha  nisms of IAEP are not completely 
understood, and no single organism or agent has been proved 
to directly cause acute eosinophilic pneumonia.
Chest radiographs of patients with IAEP show diffuse bila­
teral infiltrates, airspace opacities, interstitial reticulo­nodular 
den  si  ties and/or pleural effusion. These interstitial infiltrates 
usually progress to extensive alveolar and inter  stitial infil­
trates involving all lobes in several hours
1,2). Chest CT scans 
show diffuse areas of ground­glass attenuation, alveolar in­
filtrates, poorly defined nodules and interlobular septal thick­
ening
14). These findings of IAEP may mimic patterns seen in 
patients with congestive heart failure, except that IAEP is not 
accompanied by cardiomegaly
15). The abnormal findings in 
chest X­rays usually return to normal within 3 weeks of cor­
ticosteroid therapy. 
Most of the reported cases of IAEP showed, no peripheral 
blood eosinophilia at presentation, although they showed eo­
sinophilia in BAL fluids or alveolar spaces
2,7). Our patient also 
had extremely low peripheral blood eosinophil counts (0.1% of 
total white blood cells). Lung biopsy shows acute and organi­
zing diffuse alveolar damage with marked interstitial and 
alveolar eosi  nophilic infil  trates, which confirms the disease
1,2). 
Lung bio  psy specimen of our patient revealed marked infil­
tration of eosinophils to peribron  chiolar and perivascular 
tissues of the alveolar spaces as well as the interstitium. Unlike 
previous cases, alveolar damage was not evident. In the early 
phase of the disease, edematous alveolar septa with eosino­
philic and lymphocytic infiltrations are usually observed, 
but al  veolar damage may not be prominent. As the disease 
pro  gresses, marked fibrin exudates, hypertrophied type II 
cells and diffuse alveolar damage become evident
16). The 
pathophysiology of AEP is still not well understood. It appears 
to result from damage caused by eosinophils infiltrating the 
lung parenchyma and releasing toxic substances such as basic 
proteins, lipid mediators, and cytokines
3).
Because of the nonspecific signs and symptoms, IAEP is fre­
quently misdiagnosed as severe community­acquired pneu  monia, 
fungal infection or parasitic infestation. Radiologic and histologic 
features of drug­induced eosinophilic pneumonia are also indistin­
guishable from IAEP
5). Attention must be paid to exposure to 
various environmental dusts, toxins or cigarette smoke through a 
detailed history taking and thorough laboratory tests
5,6,17). 
Two­thirds of IAEP patients progress to respiratory failure, 
requiring mechanical ventilation
3). If the patients are properly 
treated, their prognoses are excellent. However, without the 
appro  priate diagnosis and treatment, such cases are fatal
1). 
Cortico  steroid therapy has been used in most of the reported 
cases of IAEP. Patients improve significantly within 24 to 48 
hours of corticosteroid therapy and are cured without sequelae 
and re  currence of symptoms within 2 to 12 weeks. Our patient 
was started on methylprednisolone 30 mg/kg/day. On the third 
day of treatment, she showed remarkable improvement in 
clinical symptoms and chest radiographic findings. Two weeks 
after admission, her chest radiograph showed that infiltrates 
had re  solved, and she did not require supplemental oxygenation. 
The optimal duration of corticosteroid therapy is uncertain, but 
2 to 12 weeks have been reported to be effective. IAEP is a rare 
disease and has very similar clinical features as AIP and acute 
respiratory distress syndrome (ARDS)
15). However, IAEP must 
be distinguished from AIP or ARDS because the prognosis of 
IAEP is excellent so long as corticosteroid therapy is instituted 
pro  mptly. We reported a rare case of a previously healthy 
young girl who was diagnosed with IAEP by lung biopsy and 
recovered completely after corticosteroid therapy. The early 
diagnosis of IAEP and early start of corticosteroid therapy are 
essential for lifesaving. 
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